Jane Street »

Actuate Therapeutics shares owned by Jane Street

Quarter-by-quarter ownership of Actuate Therapeutics (ACTU) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $102k 17k 6.12

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Actuate Therapeutics

BIOS Capital Management
Voss Capital
Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
Texas Capital Bank Wealth Management Services
State Street Corporation
Charles Schwab Investment Management
Rock Creek Group
Wells Fargo & Company
SFMG Wealth Advisors
Gleason Group
Northwestern Mutual Wealth Management Company
Jane Street

View all funds holding Actuate Therapeutics